Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

28.6%

2 terminated/withdrawn out of 7 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06295068Terminated

Evaluation of ARi With OpSens SavvyWire

Role: lead

NCT05491668Recruiting

Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI

Role: collaborator

NCT04929496Not ApplicableActive Not Recruiting

Physiology as Guidance to Evaluate the Direct Impact of Coronary Lesion Treatment: The PREDICT Study

Role: collaborator

NCT05070130Terminated

OpSens PRIME CLASS

Role: lead

NCT05492383Not ApplicableCompleted

SAvvyWire™ EFficacy and SafEty in Transcatheter Aortic Valve Implantation Procedures (SAFE-TAVI)

Role: lead

NCT03815032Not ApplicableCompleted

Assessing the Accuracy of the OptoWire DeuxTM in a Wire to Wire Comparison

Role: collaborator

NCT02144090Not ApplicableCompleted

Opsens Optowire for Fractional Flow Reserve - The O2 Pilot Study

Role: collaborator

All 7 trials loaded